Bone mineral density in women using depot medroxyprogesterone acetate for contraception

Abstract

These results provide evidence that contraception with depot medroxyprogesterone acetate, particularly long-term use, may adversely affect bone mineral density levels in young women aged 18-21 years. The implications for future bone health need further study.